An analysis of C.difficile environmental contamination during and following treatment for C.difficile infection

An analysis of C.difficile environmental contamination during and following treatment for C.difficile infection

Background Lower C. difficile spore counts in faeces from C. difficile infection (CDI) patients treated with fidaxomicin vs vancomycin have been observed. We aimed to determine if environmental contamination is lower in patients treated with fidaxomicin compared with those treated with vancomycin/me...

Descripció completa

Dades bibliogràfiques
Autors principals:	Davies, K, Mawer, D, Walker, AS, Berry, C, Planche, T, Stanley, P, Goldenberg, S, Sandoe, J, Wilcox, MH
Format:	Journal article
Idioma:	English
Publicat:	Oxford University Press 2020

Ítems similars

Differences in outcome according to Clostridium difficile testing method: A prospective multicentre diagnostic validation study of C difficile infection
per: Planche, T, et al.
Publicat: (2013)

Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection.
per: Planche, T, et al.
Publicat: (2013)

Fecal-free toxin detection remains the best way to detect Clostridium difficile infection
per: Planche, T, et al.
Publicat: (2015)

Clostridium difficile mixed infection and reinfection.
per: Eyre, D, et al.
Publicat: (2012)

Diverse sources of C. difficile infection identified on whole-genome sequencing.
per: Eyre, D, et al.
Publicat: (2013)

Diverse sources of C. difficile infection identified on whole-genome sequencing
per: Eyre, D, et al.
Publicat: (2013)

Epidemiology of Clostridium difficile in infants in Oxfordshire, UK: risk factors for colonization and carriage, and genetic overlap with regional C. difficile infection strains
per: Stoesser, N, et al.
Publicat: (2017)

Regarding "Clostridium difficile ribotype does not predict severe infection".
per: Walker, A, et al.
Publicat: (2013)

K-mer based prediction of Clostridioides difficile relatedness and ribotypes
per: Moore, M, et al.
Publicat: (2022)

Patient and strain characteristics associated with Clostridium difficile transmission and adverse outcomes
per: Martin, J, et al.
Publicat: (2018)

Risk factors for Clostridium difficile acquisition in infants: importance of study design.
per: Stoesser, N, et al.
Publicat: (2013)

Immunization strategies for Clostridium difficile infections.
per: Rebeaud, F, et al.
Publicat: (2012)

Comparison of control of Clostridium difficile infection in six English hospitals using whole-genome sequencing
per: Eyre, D, et al.
Publicat: (2017)

Molecular epidemiology of Clostridium difficile strains in children compared with that of strains circulating in adults with Clostridium difficile-associated infection.
per: Stoesser, N, et al.
Publicat: (2011)

Hash-based core genome multilocus sequencing typing for Clostridium difficile
per: Eyre, DW, et al.
Publicat: (2019)

Clostridium difficile infection: clinico-epidemiological perspective.
per: SYUHADA N,, et al.
Publicat: (2013)

Predictors of first recurrence of Clostridium difficile infection: implications for initial management.
per: Eyre, D, et al.
Publicat: (2012)

Multilocus sequence typing of Clostridium difficile.
per: Griffiths, D, et al.
Publicat: (2010)

Evolutionary history of the Clostridium difficile pathogenicity locus.
per: Dingle, K, et al.
Publicat: (2014)

Contribution to Clostridium difficile transmission of symptomatic patients with toxigenic strains who are fecal toxin negative
per: Mawer, D, et al.
Publicat: (2017)

Effect of age on treatment outcomes in Clostridium difficile infection.
per: Louie, T, et al.
Publicat: (2013)

Effects of control interventions on Clostridium difficile infection in England: an observational study
per: Dingle, K, et al.
Publicat: (2017)

Clinical Clostridium difficile: clonality and pathogenicity locus diversity.
per: Dingle, K, et al.
Publicat: (2011)

Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection.
per: Walker, A, et al.
Publicat: (2013)

In vitro activity of eravacycline against common ribotypes of Clostridioides difficile
per: Bassères, E, et al.
Publicat: (2020)

Effect of Advancing Age on Outcomes of Therapy for Clostridium difficile Infection.
per: Louie, T, et al.
Publicat: (2011)

Asymptomatic Clostridium difficile colonisation and onward transmission
per: Eyre, D, et al.
Publicat: (2013)

Microevolutionary analysis of Clostridium difficile genomes to investigate transmission.
per: Didelot, X, et al.
Publicat: (2012)

Microevolutionary analysis of Clostridium difficile genomes to investigate transmission
per: Didelot, X, et al.
Publicat: (2012)

Surveillance of infection severity: a registry study of laboratory diagnosed Clostridium difficile.
per: Schlackow, I, et al.
Publicat: (2012)

Fairness of financial penalties to improve control of Clostridium difficile.
per: Walker, A, et al.
Publicat: (2008)

Fairness of financial penalties to improve control of Clostridium difficile.
per: Walker, A, et al.
Publicat: (2008)

A review on the effects of probiotics and antibiotics towards Clostridium difficile infections
per: Azman, Hazirah, et al.
Publicat: (2013)

Trends in incidence and clinical outcomes of Clostridioides difficile infection, Hong Kong
per: Guo, Cosmos L. T., et al.
Publicat: (2022)

Risk factors and treatment outcomes of severe Clostridioides difficile infection in Singapore
per: Tay, Hui Lin, et al.
Publicat: (2020)

Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin.
per: Cornely, O, et al.
Publicat: (2012)

Clostridium difficile Associated Risk of Death Score (CARDS): A novel severity score to predict mortality among hospitalized patients with Clostridium difficile infection
per: Cribb Fabersunne, C., et al.
Publicat: (2017)

The clinical and environmental spread and diversity of toxigenic Clostridium difficile diarrhea in the region of the Middle East.
per: N., Sadeghifard, et al.
Publicat: (2010)

Clostridium difficile surveillance: harnessing new technologies to control transmission.
per: Eyre, D, et al.
Publicat: (2013)

Gut metabolites predict Clostridioides difficile recurrence
per: Dawkins, Jennifer J., et al.
Publicat: (2022)